Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. - Wikidata - awgldk - TriplyDB

Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.

Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.

http://www.wikidata.org/entity/Q33815241

about

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas.Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion Anti-receptor for advanced glycation end products therapies as novel treatment for abdominal aortic aneurysm Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.Molecular virology of Epstein-Barr virus.Epstein-barr virus-induced changes in B-lymphocyte gene expression.Expression of matrix metalloproteinase 9 in nasopharyngeal carcinoma and association with Epstein-Barr virus infection.Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma.Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinoma Japanese encephalitis virus induces matrix metalloproteinase-9 expression via a ROS/c-Src/PDGFR/PI3K/Akt/MAPKs-dependent AP-1 pathway in rat brain astrocytes KSHV-Mediated Regulation of Par3 and SNAIL Contributes to B-Cell Proliferation Intracranial aneurysm formation in type-one diabetes rats Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.Aberrantly hypermethylated Homeobox A2 derepresses metalloproteinase-9 through TBP and promotes invasion in Nasopharyngeal carcinoma.Epstein-Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin.LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway.Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1.Expression of the matrix metalloproteinase 9 in Hodgkin's disease is independent of EBV status Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis A trypsin-like serine protease is involved in pseudorabies virus invasion through the basement membrane barrier of porcine nasal respiratory mucosa Model of vascular desmoplastic multispecies tumor growth.C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes.

P2860

Q24804219-944F48EB-8094-46E2-80C2-790D63B01A60 Q28472867-A97680F8-641E-45F3-BC3D-98CD34BD3A26 Q34067128-930B01DB-2F40-4DDE-B73E-14C2E0F8190E Q34089491-8CB8624A-A42C-4D1F-9650-460A8252EDF3 Q34131747-83E40C3B-FB4A-43C8-93A7-6E1BAC5006C4 Q34225554-3EAF97FD-BBA5-428A-A467-ABD93864AA6B Q34347958-4A5ED5A6-36F3-4503-87D6-4F4C899E24FF Q34423236-FACAE5C8-86DC-47E6-95D0-5453392F98FB Q34611577-B2D91F69-31BF-4A39-BCCC-873057FAA58A Q34745799-583D662D-30BA-4A06-82CD-95C13E218BF2 Q34901718-DEA03BBB-ED9A-4565-BDA2-36F677FC7192 Q35005158-54D10AB5-1DC6-4644-9020-0BD7A81DA15F Q35635449-F89CC2F2-EB96-409D-80A2-5512F422F78B Q35746620-E897DB44-54E6-43CE-B326-C2C9A0B588D4 Q35818409-1434CBAF-5D07-4EA5-984E-3C54330A9C9E Q36087231-1A6480E0-C7F1-4CBC-A561-040DBEA25011 Q36976259-2ECEAFD4-6CA1-466C-A6A4-8CA851C2C4D8 Q37256742-51EB338D-208A-4EFD-87C8-CED432534034 Q37420206-7466E9B3-3709-4CBF-BF3A-1A895F186C95 Q38826798-AF901FA9-3031-4764-A6B0-C3A430CB0AEB Q38927489-8C18C582-D32B-46EC-8FDF-9138D87B3DAD Q39596927-4F846375-8CF6-4260-A820-6469D3BA020E Q40024497-BC475FFC-E42A-46D0-97B0-7E546AED20B9 Q40398026-F9E22D1E-E3B3-4CB0-B364-7AF9AEA1A489 Q40868229-6C0FC58C-1617-44B8-A84A-246D96EAAE17 Q41681789-18D6B4CF-F63E-4AF5-91AD-F9C5982C952D Q42676834-9CF635CF-A66B-4B42-B8E3-872932840C31 Q42728621-19A7D644-D25E-4C73-A474-0120B05A082B Q46362794-6627F90E-F724-4D1E-B917-15027CA41365 Q50045673-C4DCCA8E-C4CD-4751-B2C5-95E6969DE1CC

P2860

Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.

http://www.wikidata.org/entity/Q33815241

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@ast

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@en

type

label

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@ast

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@en

prefLabel

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@ast

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@en

P1433

Q33815241-DEB01C00-D4EE-4662-8581-F75A265CF455

P1476

Q33815241-3FAFAA01-7259-4BB6-B23B-94BA1CBC0540

P2093

Q33815241-68EDE7C8-7CAF-46E0-8A35-B3180C80D2D2

Q33815241-70E2D2DE-365B-4155-A6E9-100F2D0203BA

Q33815241-933D51EB-5956-477D-80D0-DBE12E8AE112

Q33815241-94D5C0B6-24B6-447A-8AE1-57DBD42B67A3

Q33815241-CF83FD2C-6B60-4B5D-8735-86D5B6761477

Q33815241-E6E58484-6512-4EFD-A725-CAAC1B416110

Q33815241-FFAE4386-26E2-4F9F-A320-CDDCA9EC28AA

P2860

Q33815241-030FB944-9CF5-48BC-97D0-7A662930E26D

Q33815241-07C0A9C6-0832-4232-A81A-8D608B6A020B

Q33815241-0F867EA0-61A8-45C5-AEE7-7577C22C30F4

Q33815241-14185723-53D4-4FC9-A20B-28316CFDFF95

Q33815241-14997967-25B1-434D-AAA1-22C4FE98704F

Q33815241-16FFA285-5B7A-4719-9681-F3C82EE5DF3C

Q33815241-19383C65-CD07-40A5-8620-7186E22A5A15

Q33815241-2C4B09D7-5550-4681-8FCF-C2F1BAD98EB5

Q33815241-3263336F-E0DC-4AB8-BA3D-12A15CA32E04

Q33815241-328789A9-8895-4EE7-880B-3B44339ED499

P304

Q33815241-E2FBD9BD-AFE8-4732-B5C0-58578528FD36

P31

Q33815241-79BB107F-61D3-4B20-9E26-673DE841D1D7

P433

Q33815241-4A0BD666-AF15-4B1F-97C7-717E0EA70093

P478

Q33815241-168D5997-7EE5-4417-9D9B-E1093069D8D4

P577

Q33815241-B84E5032-3C82-4601-9CF8-87C9DE1F31B4

P698

Q33815241-9E71E8B2-1313-48CF-BF43-11FB48A607D9

P921

Q33815241-21C54F23-B5BF-44C6-B157-B47CEB8D3777

P932

Q33815241-672888E5-D80B-4A2D-9038-EFA3E2B19218

P1433

Journal of Virology

P1476

Matrix metalloproteinase 9 exp ...... al activation regions 1 and 2.

@en

P2093

H Sato

http://www.w3.org/2001/XMLSchema#string

H Takeshita

http://www.w3.org/2001/XMLSchema#string

J S Pagano

http://www.w3.org/2001/XMLSchema#string

M Furukawa

http://www.w3.org/2001/XMLSchema#string

N Raab-Traub

http://www.w3.org/2001/XMLSchema#string

T Yoshizaki

http://www.w3.org/2001/XMLSchema#string

W E Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family

A matrix metalloproteinase expressed on the surface of invasive tumour cells

Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase

Metalloproteinases and their inhibitors in matrix remodeling

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.

P304

5548-5555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10364303

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

112612

http://www.w3.org/2001/XMLSchema#string